Eli Lilly and Company
Notch pathway signaling inhibitor compounds

Last updated:

Abstract:

The present invention provides the following compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions containing said compounds useful as a Notch pathway signaling inhibitor for the treatment of named cancers, sensorineural hearing loss caused by auditory hair cell loss, and inducing auditory hair cell generation. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

1 Jul 2016

Issue date:

22 Oct 2019